MedTrace Logo

Lariboisière Cognitive Assessment: Evaluation of the 1-year Outcomes

NCT06171568 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-05-31

No results posted yet for this study

Summary

Cognitive sequelae are common following acquired brain injuries. However, their detection can be challenging, particularly in acute care units such as neurosurgery. Specific screening in acute phase is critical for early detection and proper orientation. The Lariboisière cognitive assessment (Cog-First) is a brief cognitive evaluation conducted on a touch-screen tablet for patients with acquired brain injuries in the acute phase, which is integrated into routine care in Lariboisière.

The objective of this project is to evaluate the one-year cognitive and functional outcomes of patients who have undergone hospitalization in neuro-surgery. The primary aim is to assess whether the systematic pre-discharge assessment (Cog-First) performed as part of routine care can predict a poor functional prognosis and help identify at-risk patients earlier and more effectively.

Conditions

  • Brain Injuries

Interventions

OTHER

Tests and questionnaires

1 year after discharge from neurosurgery department, included patients will answer to the: * Modified Rankin Scale; * Instrumental Activities of Daily Living (IADL) questionnaire; * Montreal Cognitive Assessment (MoCA); * Frontal assessment battery (BREF); * Rivermead questionnaire; * Short Form (36) Health Survey (SF-36) * Community Integration Questionnaire - Revised (CIQ-R) * Posttraumatic stress disorder CheckList (PCL-5)

Sponsors & Collaborators

  • SBT Human(s) Matter

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Emmanuel Mandonnet, MD, PhD · Assistance Publique - Hôpitaux de Paris

  • Alexis Schnitzler, MD, PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-22
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06171568 on ClinicalTrials.gov